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  Mitochondrial dynamics and distribution is critical for their role in bioenergetics and cell survival. 
We investigated the consequence of altered fission/fusion on mitochondrial function and motility in 
INS-1E rat clonal β-cells. Adenoviruses were used to induce doxycycline-dependent expression of wild 
type (WT-Mfn1) or a dominant negative mitofusin 1 mutant (DN-Mfn1). Mitochondrial morphology and 
motility were analyzed by monitoring mitochondrially-targeted red fluorescent protein. Adenovirus- 
driven overexpression of WT-Mfn1 elicited severe aggregation of mitochondria, preventing them from 
reaching peripheral near plasma membrane areas of the cell. Overexpression of DN-Mfn1 resulted in 
fragmented mitochondria with widespread cytosolic distribution. WT-Mfn1 overexpression impaired 
mitochondrial function as glucose- and oligomycin-induced mitochondrial hyperpolarization were 
markedly reduced. Viability of the INS-1E cells, however, was not affected. Mitochondrial motility was 
significantly reduced in WT-Mfn1 overexpressing cells. Conversely, fragmented mitochondria in DN- 
Mfn1 overexpressing cells showed more vigorous movement than mitochondria in control cells. 
Movement of these mitochondria was also less microtubule-dependent. These results suggest that 
Mfn1-induced hyperfusion leads to mitochondrial dysfunction and hypomotility, which may explain 
impaired metabolism-secretion coupling in insulin-releasing cells overexpressing Mfn1.
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INTRODUCTION
  The pancreatic β-cell is a specialized metabolic sensor 
of the body that releases insulin to maintain blood glucose 
levels in a narrow range. Glucose uptake elicits down- 
stream signals accelerating the exocytosis of insulin gran-
ules in β-cell [1]. In this process, generation of ATP and 
other coupling factors from mitochondria play an important 
role [2]. Disturbing mitochondrial function in pancreatic β- 
cells impairs metabolism-secretion coupling and promotes 
the development of type 2 diabetes [2,3]. Mutations in mi-
tochondrial DNA have been described that result in mater-
nally inherited diabetes [4]. Furthermore, islet β-cells from 
diabetic patients display mitochondrial dysfunction [5].
  Mitochondria are dynamic organelles, which continuously 
divide and fuse. These processes are mediated by fission 
and fusion proteins. The two main components of the fission 
machinery are Fis1 and Drp1 [6]. Drp1 translocates from 
the cytosol to predetermined fission sites on the mitochon-
dria, and constricts the membrane by a GTPase-dependent 
mechanism [7]. Fis1 was suggested to recruit Drp1 to the 
mitochondrial outer membrane [8]. Mitochondrial fission 
factor has been reported as another Drp1 receptor in the 
fission process [9,10]. Inhibition of the fission proteins pro-
tects against apoptosis [11], but also impairs mitochondrial 
function by decreasing autophagocytosis [12]. 
  Mitochondrial fusion is mediated by mitofusin 1 (Mfn1) 
and mitofusin 2 (Mfn2) in the outer membrane as well as 
Opa1 in the inner mitochondrial membrane [6]. Both Mfn1 
and Mfn2 have a GTPase domain in the N-terminus and 
loss of function mutation in this domain disrupts fusion ac-
tivity resulting in excessive fission when overexpressed 
[13]. Deletion of the Mfn1 or Mfn2 genes in the mouse re-
sults in mitochondrial dysfunction and embryonic lethality 
[14]. Mutations in Mfn2 cause a neurological disease affect-
ing sensory and motor peripheral neurons [15]. 
  Mitochondria continuously move in the cytosol, which is 
required for optimal cell function especially when the 
amount of the organelles is limiting [16]. This motility en-72 KS Park, et al
Fig. 1. Mitochondrial morphology of INS-1E cells overexpressing wild type (WT-Mfn1) and dominant negative mitofusin 1 (DN-Mfn1). After 
infection with adenoviruses coding WT-Mfn1 or DN-Mfn1, INS-1E cells were cultured with or without doxycycline for 48 hrs. Mitochondria 
in non-induced control cells (A) or cells overexpressing WT-Mfn1 (B) or DN-Mfn1 (C) were observed by using a confocal microscope after 
cotransfection of plasmids encoding mitochondria-targeted RFP (mitoRFP, red) and plasmalemma-targeted GFP (green).
ables mitochondria to supply ATP and other metabolites 
even to distal parts of the cell or allows the organelle to 
buffer local Ca
2＋ increases efficiently [17]. Cytoskeletal 
tracks and several motor proteins responsible for mitochon-
drial movement have been identified [18]. Kinesin and dy-
nein are involved in antegrade or retrograde movement of 
mitochondria along microtubules. Milton and Miro act as 
adaptors localized on mitochondria [17]. Miro is a Rho- 
GTPase with Ca
2＋ binding motifs [19]. This protein may 
mediate Ca
2＋-induced inhibition of mitochondrial motility 
in order to recruit active mitochondria to sites of local Ca
2＋ 
increase [20]. In pancreatic β-cells, mitochondrial local-
ization and ATP supply to peripheral area might be im-
portant, because local rises of the ATP/ADP ratio are most 
likely required to induce the closure of plasmalemmal KATP 
channels leading to voltage-sensitive Ca
2＋ influx and in-
sulin exocytosis [21].
  We previously reported that mitochondrial fragmentation 
does not have a negative impact on mitochondrial function 
and glucose-stimulated insulin secretion in INS-1E cells 
[22]. On the other hand, overexpression of wild type mitofu-
sin 1 (WT-Mfn1) evoked hyperfusion of the mitochondria 
with lowered cellular ATP levels, increased lactate pro-
duction and impaired insulin release [22]. In this study, 
we report that WT-Mfn1 overexpression impairs mitochon-
drial motility and function in INS-1E cells as assessed by 
live cell confocal imaging and measurement of the mi-
tochondrial membrane potential. These defects were not ob-




  INS-1E rat clonal β-cells were cultured in a humidified 
atmosphere (37
oC) containing 5% CO2 in complete medium 
composed of RPMI 1640 (Invitrogen, Carlsbad, CA, USA) 
supplemented with 10% FCS (Invitrogen), 1 mM sodium 
pyruvate, 50 μM 2-mercaptoethanol, 2 mM glutamine, 10 
mM HEPES, 100 U/ml penicillin, and 100 μg/ml strepto-
mycin. 
Adenovirus infection
  Doxycycline-inducible adenoviruses encoding WT-Mfn1 
and DN-Mfn1 were constructed as described previously 
[22]. One day after plating INS-1E cells, adenoviruses en-
coding the transgene were applied together with the ad-
enovirus expressing the reverse tetracycline-transactivator 
to INS-1E cells for 90∼120 min 1 day after seeding [23]. 
Before the experiment, cells were cultured for 48 hours with 
or without doxycycline (500 ng/ml).
Mitochondrial morphology
  Mitochondria of INS-1E cells were visualized by trans-
fecting the mitochondrially-targeted red fluorescent protein 
(mitoRFP) plasmid using lipofectamine 2,000 (Invitrogen) 
followed by infection with adenoviruses. Mitochondrial mor-
phology was observed 48 hrs after infection and analyzed 
using a confocal laser-scanning microscope (LSM510meta, 
Zeiss, Switzerland) after fixation with 4% paraformalde-
hyde.
Measurement of mitochondrial membrane potential
  INS-1E cells were seeded (5×10
4 cells/well) on black-wal-
led 96 wellplates and infected with adenoviruses. Cells 
were cultured in medium with or without doxycycline for 
48 hours, and then loaded with 500 nM of JC-1 (Invitrogen) 
in KRBH buffer (2.8 mM glucose) for 30 minutes at 37
oC. 
After washing, JC-1 fluorescence was measured from cells 
in KRBH buffer using a FlexStation (Molecular Devices Co., 
Sunnyvale, CA, USA) as described previously [22].
MTT assay
  3-(4,5-dimethylhioazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) was purchased from Sigma (St. Louis, MO, 
USA). INS-1E cells seeded on 96-well microtiter plates were 
infected with different doses (30∼120 ifu/cell) of adenovirus 
coding for WT-Mfn1 and incubated for 48 hours in medium 
containing 500 ng/ml doxycycline. Cells were further in-
cubated with MTT (100 μg/well), and solubilized with 
DMSO. Absorbance of each well at 570 nm and 650 nm Mitochondrial Hyperfusion Decreases Motility 73
Fig. 2. Overexpression of wild type mitofusin 1 (WT-Mfn1) impairs mitochondrial function. (A) Mitochondrial membrane potential was 
measured in WT-Mfn1-overexpressing INS-1E cells by using a fluorescence spectrophotometer after JC-1 (500 nM) loading. Changes in 
fluorescence ratio were normalized to the ratio difference between resting (100%) and FCCP-induced depolarization (0%) and expressed 
as the percentage of change (R-RFCCP)/(R0-RFCCP)-100). Averaged results (three traces for each condition) from non-induced (black line) and 
induced WT-Mfn1 expression (gray line) are shown including error bars (S.E.). (B) The MTT assay was used to estimate cell viability. 
INS-1E cells seeded on 96-well microtiter plates were infected with different doses (30∼120 ifu/cell) of adenovirus coding for WT-Mfn1 
and incubated for 48 hours in medium containing 500 ng/ml doxycycline. (C) The fraction of apoptotic cells over-expressing WT-Mfn1 was 
determined using the TUNEL assay. All nuclei were stained with DAPI (1 μg/ml for 5 minutes) and data were expressed as the percent 
of TUNEL positive cells per DAPI-stained cell.
was measured using an ELISA reader (Molecular Devices 
Co.). The difference in absorption (A570-A650) was then 
calculated.
TUNEL assay
  The fraction of apoptotic cells over-expressing WT-Mfn1 
was determined using the TUNEL assay (In Situ Cell 
Death Detection Kit, Roche Diagnostics) according to the 
manufacturer’s instructions. All nuclei were stained with 
DAPI (1 μg/ml for 5 minutes) and data were expressed as 
the percent of TUNEL positive cells per DAPI-stained cells.
Mitochondrial motility measurement
  After transfecting mitoRFP, mitochondrial images were 
obtained using an inverted microscope (Zeiss, Switzerland) 
with confocal spinning disk (QLC100, VisiTech, UK). Image 
series were analyzed by Metamorph software (Universal 
Imaging, Molecular Devices Co.). The number of moved pix-
els per second were normalized to total pixels above the 
threshold (mitochondria) and used to calculate a ‘motility 
index’.
Statistical analysis 
  Values are given as mean±S.E. p values were obtained 
by Student’s t-test or one-way ANOVA.
RESULTS
  INS-1E cells were infected with adenoviruses encoding 
WT-Mfn1 or DN-Mfn1. Infection with these viruses in com-
bination with reverse tetracycline-transactivator induced 
doxycycline-dependent expression in INS-1E cells as dem-
onstrated previously [22]. To follow mitochondrial morphol-
ogy and localization, we transiently transfected INS-1E 
cells with mitoRFP and plasmalemma-targeted GFP using 
lipofection. As shown in Fig. 1A, Mitochondria in control 
non-induced (without doxycycline incubation) cells showed 
a filamentous pattern of mitochondria distributed from the 
perinuclear area to the cell periphery. Overexpression of 
WT-Mfn1 caused aggregation of the mitochondria by pro-
moting the fusion process. The mitochondria in WT-Mfn1- 
overexpressing cells did not reach the subplasmalemmal 
area (Fig. 1B). Conversely, DN-Mfn1 with a point mutation 
in the GTPase domain (T109A) caused fragmented mi-
tochondria, which were distributed throughout the cytosol 
(Fig. 1C).
  To assess mitochondrial function after manipulation of 
the fission/fusion machinery, we measured mitochondrial 
membrane potential (Δψm) changes using the fluorescent 
dye JC-1. This dye permits ratiometric recording of Δψm 
changes [22]. Glucose induces hyperpolarization of Δψm. 
Doxycycline (500 ng/ml) induction of WT-Mfn1 attenuated 
this hyperpolarization (Fig. 2A). Blockage of the F1F0- 
ATPase by oligomycin is known to elicit hyperpolarizing 
changes in well-functioning mitochondria [24]. Dysfunctio-
nal mitochondria maintain Δψm by reversal of the F1F0- 
ATPase, resulting in ATP consumption. Oligomycin in such 
dysfunctional mitochondria causes depolarization. In WT- 
Mfn1 overexpressing cells, oligomycin (2.5 μg/ml)-induced 
hyperpolarization of Δψm was strongly decreased when 
compared to control cells (Fig. 2A).
  Mitochondrial aggregation and the depolarization of Δψm 
may cause cell death. To follow cell viability in cells over-
expressing WT-Mfn1, we used the colorimetric MTT assay. 
The amount of formazan reaction product formed in the 
MTT assay reflects the mitochondrial enzyme activity, 74 KS Park, et al
Fig. 3. Analysis of mitochondrial motility in INS-1E cells overexpressing wild type (WT-Mfn1) and dominant negative mitofusin 1 (DN-Mfn1).
Mitochondria of INS-1E cells were visualized by transfecting the mitochondrially-targeted red fluorescent protein (mitoRFP) plasmid followed
by infection with adenoviruses coding for WT-Mfn1 or DN-Mfn1. Mitochondrial images were obtained 48 hrs after infection by using a 
confocal microscope (A∼C). Two consecutive mitochondrial images were binarized and colored differently (red and green) using software. 
Yellow pixels in a color-combined image are overlapped area implying not moved (D∼F).
which allows assessing the cell viability. INS-1E cells were 
infected with increasing concentrations of WT-Mfn1. Even 
at the highest concentration of adenovirus particles (120 
ifu/cell), WT-Mfn1 did not significantly altered cell viability 
(Fig. 2B). This result also implies that the mitochondrial 
enzyme activity at least involved in formazan reaction was 
not affected by WT-Mfn1 overexpression, although there 
was a functional deterioration of mitochondria. TUNEL as-
says further demonstrated that apoptosis was not induced 
by WT-Mfn1 overexpression (Fig. 2C). In contrast, Fis1 
overexpression caused apoptotic cell death as reported pre-
viously [22].
  We analyzed mitochondrial motility from series of con-
focal images (Fig. 3). Elongated mitochondria of control 
INS-1E cells displayed worm-like wriggling movements. 
Compared to control cells, WT-Mfn1 overexpressing cells 
had less motile, clumped mitochondria. Mitochondrial mo-
tion can be quantified by following changes of mitoRed pos-
itive areas. Fig. 3D∼F are representative illustrations com-
bining two consecutive images (red- and green-colored) af-
ter binarization. We measured the moved mitochondrial 
pixels and expressed as an arbitrary motility index as de-
scribed in Materials and Methods. Consistent with our 
qualitative observations, mitochondrial aggregates after 
WT-Mfn1 overexpression had a much lower motility index 
than control cells (Fig. 4D). Conversely, fragmented mi-
tochondria in DN-Mfn1 overexpressing cells showed fast 
random movement like Brownian motion. Microtubule-de-
pendent movement was estimated by the application of no-
codazole which interferes with polymerization of micro-
tubules [20]. Nocodazole significantly attenuated the mi-
tochondrial motility in control cells, but showed less in-
hibition in DN-Mfn1 overexpressing cells (Fig. 4E). FCCP, 
a mitochondrial uncoupler, elicited a further inhibition of 
motility maybe due to collapse of Δψm resulting in ATP 
depletion [25] or cytosolic Ca
2＋ increase [26]. Mitochondrial 
motility in WT-Mfn1 overexpressing cells was affected by 
neither nocodazole, nor FCCP.
DISCUSSION
  Mitochondrial fusion is an essential process. Knockout 
mice deficient in either Mfn1 or Mfn2 display mid-gesta-
tional lethality [14]. In man, mutations in fusion genes can 
cause neurodegenerative diseases [15]. Fusion may be par-
ticularly important as it mediates the mixing of mitochon-
drial content where healthy mitochondria may be able to 
complement dysfunctional mitochondria [27]. Mitofusins al-
so are known to have an impact on cell metabolism. Glucose 
oxidation, oxygen consumption, and mitochondrial mem-
brane potential are lowered by loss of Mfn2 function [28]. 
Mfn2 tethers the ER to mitochondria, influences ER struc-
ture [29], regulates ER calcium homeostasis and store-oper-
ated calcium entry [30]. GTPase activity of Mfn1 and Mfn2 
is an essential process for the fusion. Mfn1 GTPase activity 
is much higher than that of Mfn2 [31]. In this study, we 
overexpressed either wild type or GTPase-deficient Mfn1 
and observed pronounced differences in mitochondrial mor-
phology, dynamics, and function in INS-1E cells. Previou-Mitochondrial Hyperfusion Decreases Motility 75
Fig. 4. Mitochondrial motility is decreased by overexpressing wild type mitofusin1 (WT-Mfn1). (A∼C) Using confocal images of mitochondria
in INS-1E cells, the number of moved pixels per second were normalized to total pixels above the threshold (mitochondria) and used to 
calculate a ‘motility index’. Basal mitochondrial motility (D) and nocodazole-induced inhibition (E) were compared among control, WT-Mfn1-, 
or dominant-negative Mfn1 (DN-Mfn1)-overexpressing cells. The number of experiments is 3∼7, and the results are presented as means±S.E.
* and ** denote p＜0.05, and ＜0.01, respectively.
sly, we had demonstrated that WT-Mfn1 overexpression 
markedly reduced glucose-stimulated insulin secretion in 
this cell type [22]. The here presented data suggest that 
impaired metabolism-secretion coupling in WT-Mfn1 over-
expressing cells is related to attenuated mitochondrial mo-
tility and function.
    Hyperfusion of mitochondria due to WT-Mfn1 over-
expression reduced glucose- and oligomycin-induced hyper-
polarization. The extent to which mitochondria hyperpola-
rize in response to oligomycin reflects the quantity of func-
tional mitochondria actively synthesizing ATP. Thus, over-
expression of WT-Mfn1 increased the amount of dysfunc-
tional mitochondria in the INS-1E cell population. These 
results explain our previous findings that INS-1E cells 
overexpressing WT-Mfn1 have reduced cellular ATP levels 
and enhanced lactate production [22]. One possible mecha-
nism resulting in mitochondrial dysfunction is loss of mi-
tochondrial autophagy (mitophagy) following Mfn1-induced 
mitochondrial aggregation. Mitophagy acts as a quality con-
trol mechanism by degrading dysfunctional mitochondrial 
fragments. Silencing of Fis1 or overexpression of dominant 
negative Drp1 deteriorates the ability of mitochondria to 
undergo mitophagy [12]. Compromised mitophagy causes 
the accumulation of oxidized mitochondrial proteins, re-
duces cellular respiration, and decreases glucose-stimu-
lated insulin secretion [12]. Defects in mitophagy due to 
WT-Mfn1-induced hyperfusion may increase the proportion 
of dysfunctional mitochondria and therefore lower total mi-
tochondrial activity. 
  For insulin secretion, mitochondrial movement to the cell 
periphery may be critical in order to supply ATP close to 
KATP channels to initiate β-cell electrical activity finally re-
sulting in insulin granule exocytosis. To date, mitochon-
drial motility has been investigated mainly in neuronal 
cells which require mitochondria at sites distant from the 
cell body. We observed that INS-1E cells as well as pancre-
atic β-cells have tubular networks of filamentous mitochon-
dria distributed throughout the cytosol [22]. In control 
INS-1E cells, the mitochondria were undergoing continuous 
wriggling movements and reached near plasma membrane 
areas of the cytosol. WT-Mfn1 overexpression caused ag-
gregation and marked inhibition of the mitochondrial mo-
tility, preventing them from reaching the subplasma mem-
brane areas. These findings are similar to those reported 
in neural cells with conditional knockout of Drp1 [32]. 
  It has been reported that embryonic fibroblasts of mitofu-
sin knockout mice have spherical highly fragmented mi-
tochondria, which display disorganized random movement 76 KS Park, et al
[14]. Similarly, mitochondria of INS-1E cells overexpres-
sing DN-Mfn1 showed enhanced motility of fragmented mi-
tochondria reaching even peripheral areas of the cell. In 
these cells, nocodazole inhibited mitochondrial movements 
less than in control cells. Overexpression of DN-Mfn1 may 
disrupt the association of the mitochondria to the micro-
tubule system therefore allow random mitochondrial move-
ment. Following DN-Mfn1 overexpression, mitochondria 
are more fragmented and possibly more likely to undergo 
mitophagy. In these cells, we reported that mitochondrial 
function was not reduced, but even enhanced [22]. Consis-
tently, DN-Mfn1 neither increased apoptosis nor impaired 
metabolism-secretion coupling in these cells [22]. We sug-
gest that fragmentation of mitochondria at least in some 
condition is beneficial in order for the cell to cope with vari-
ous metabolic and/or oxidative stresses.
  A large number of studies demonstrated that an im-
balance of mitochondrial fission/fusion can secondarily also 
affect organelle function and motility. The exact roles of 
the mitochondrial-shaping proteins and their cell-type spe-
cific functions remain unclear. This study shows the neg-
ative impact of hyperfusion due to Mfn1 overexpression on 
mitochondrial activity. These defects likely explain im-
paired metabolism-secretion coupling in insulin-releasing 
cells overexpressing Mfn1. Further investigations to un-
ravel the factors controlling mitochondrial morphology and 
motility are needed. This may allow us to identify patho-
physiologic mechanisms linked to defects in mitochondrial 
dynamics and to develop therapeutic approaches.
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